| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lexaria Bioscience Corp. | Chief Financial Officer | common shares | 1,954 | $4,084 | $2.09 | 14 Oct 2022 | Direct |
| Lexaria Bioscience Corp. | Chief Financial Officer | Stock Options | 46,000 | 14 Oct 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LEXX | Lexaria Bioscience Corp. | 14 Oct 2022 | 1 | $252 | 4/A | Chief Financial Officer | 18 Oct 2022, 18:31 |
| LEXX | Lexaria Bioscience Corp. | 29 Aug 2022 | 1 | $0 | 4 | Chief Financial Officer | 29 Aug 2022, 17:08 |
| LEXX | Lexaria Bioscience Corp. | 01 Sep 2021 | 1 | $0 | 4 | Chief Financial Officer | 02 Sep 2021, 13:19 |
| LEXX | Lexaria Bioscience Corp. | 08 Jun 2021 | 1 | $0 | 4 | Chief Financial Officer | 09 Jun 2021, 12:38 |
| LEXX | Lexaria Bioscience Corp. | 07 May 2021 | 1 | $0 | 4 | Chief Financial Officer | 09 Jun 2021, 12:32 |